[FG] Heinzelmann Viola

Einig, Sabrina et al. (2024) ‘Impact of Sonographer Experience, Insonation Angle, and Bladder Filling on Uterine Artery Doppler Measurements in the First Trimester of Pregnancy’, Journal of Ultrasound in Medicine, 43(12), pp. 2375–2383. Available at: https://doi.org/10.1002/jum.16572.

Speck, Nicole E. et al. (2024) ‘The Importance of Patient-Reported Outcome Measures (PROMs) in Oncological Vulvoperineal Defect Reconstruction: A Systematic Review’, Current Oncology. 25.10.2024, 31(10), pp. 6300–6313. Available at: https://doi.org/10.3390/curroncol31100470.

Zwimpfer, Tibor A et al. (2024) ‘Predictive value of homologous recombination deficiency status for survival outcomes in primary tubo-ovarian high-grade serous carcinoma’, Cochrane Database of Systematic Reviews. 23.09.2024, 2024(9). Available at: https://doi.org/10.1002/14651858.cd015896.

Heidinger, Martin et al. (2024) ‘Association of relative resection volume with patient-reported outcomes applying different levels of oncoplastic breast conserving surgery – A retrospective cohort study’, European Journal of Surgical Oncology, 50(9), pp. 1–9. Available at: https://doi.org/10.1016/j.ejso.2024.108478.

Cumin, Cécile et al. (2024) ‘Highly Sensitive Spatial Glycomics at Near-Cellular Resolution by On-Slide Derivatization and Mass Spectrometry Imaging’, Analytical Chemistry [Preprint]. Available at: https://doi.org/10.1021/acs.analchem.3c05984.

Einig, Sabrina et al. (2024) ‘Pelvic Pain of Myofascial Origin in Women: Correlation with Lower Urinary Tract Symptoms’, Advances in Urology, 2024. Available at: https://doi.org/10.1155/2024/5568010.

Förster, Christiane E. et al. (2024) ‘Comparison of different suture techniques for laparoscopic vaginal cuff closure’, Scientific Reports, 14. Available at: https://doi.org/10.1038/s41598-024-55586-5.

Grašič Kuhar, Cvetka et al. (2024) ‘Prognostic Importance of Axillary Lymph Node Response to Neoadjuvant Systemic Therapy on Axillary Surgery in Breast Cancer—A Single Center Experience’, Cancers, 16. Available at: https://doi.org/10.3390/cancers16071306.

Harter, Philipp et al. (2024) ‘Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer’, Bulletin du Cancer, 111, pp. 277–284. Available at: https://doi.org/10.1016/j.bulcan.2023.02.011.

Kasikova, Lenka et al. (2024) ‘Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer’, Nature Communications, 15. Available at: https://doi.org/10.1038/s41467-024-46873-w.

Labrosse, Kathrin B. et al. (2024) ‘Intracorporeal vs. extracorporeal open and closed knot tying techniques in laparoscopy: A randomized, controlled study’, Heliyon. 26.01.2024, 10(3), p. e25178. Available at: https://doi.org/10.1016/j.heliyon.2024.e25178.

Stiegeler, Nadja et al. (2024) ‘Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group’, Frontiers in Oncology, 14. Available at: https://doi.org/10.3389/fonc.2024.1387281.

Zwimpfer, Tibor A. et al. (2024) ‘Management of Patients with Hypersensitivity to Platinum Salts and Taxane in Gynecological Cancers: A Cross-Sectional Study by the European Network of Young Gynaecologic Oncologists (ENYGO)’, Cancers, 16. Available at: https://doi.org/10.3390/cancers16061155.

Zwimpfer, T.A. et al. (2024) ‘Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers’, Cancer Medicine, 13. Available at: https://doi.org/10.1002/cam4.6840.

Zwimpfer, Tibor A. et al. (2024) ‘Comparison of 2D 4K vs. 3D HD laparoscopic imaging systems in bariatric surgery: study protocol for a randomized controlled prospective trial’, Trials, 25. Available at: https://doi.org/10.1186/s13063-024-07983-4.

Colombo, N. et al. (2023) ‘INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line’, British Journal of Cancer, 128, pp. 1503–1513. Available at: https://doi.org/10.1038/s41416-022-02108-7.

Estermann, Manuela et al. (2023) ‘A 3D multi-cellular tissue model of the human omentum to study the formation of ovarian cancer metastasis’, Biomaterials, 294. Available at: https://doi.org/10.1016/j.biomaterials.2023.121996.

Herzog, Emilie M et al. (2023) ‘How to break bad news and how to learn this skill: Results from an international North-Eastern German Society for Gynecological Oncology (NOGGO) survey among physicians andthe physicians are generally alone with the patient; Only 57.4% medical students with 1089 participants’, International Journal of Gynecological Cancer, 33, pp. 1934–1942. Available at: https://doi.org/10.1136/ijgc-2023-004693.

Knipprath-Mészáros, Alexandra Maria et al. (2023) ‘High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma’, Gynecologic Oncology, 174, pp. 182–189. Available at: https://doi.org/10.1016/j.ygyno.2023.05.005.

Martinez, Alejandra et al. (2023) ‘PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): A GINECO, ENGOT, and GCIG study’, International Journal of Gynecological Cancer, 33, pp. 293–298. Available at: https://doi.org/10.1136/ijgc-2022-004223.

Woopen, Hannah et al. (2023) ‘Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors—Results of Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey’, Cancers, 15. Available at: https://doi.org/10.3390/cancers15225428.

Zwimpfer, Tibor A. et al. (2023) ‘Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event’, World Journal of Surgical Oncology, 21. Available at: https://doi.org/10.1186/s12957-023-02918-w.

Zwimpfer, Tibor A. et al. (2023) ‘Low grade serous ovarian cancer – A rare disease with increasing therapeutic options’, Cancer Treatment Reviews, 112, p. 102497. Available at: https://doi.org/10.1016/j.ctrv.2022.102497.

Coelho R et al. (2022) ‘Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer.’, Cell death & disease, 13(10), p. 909. Available at: https://doi.org/10.1038/s41419-022-05347-x.

Chase DM et al. (2022) ‘Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial.’, Gynecologic oncology, 166(3), pp. 494–502. Available at: https://doi.org/10.1016/j.ygyno.2022.06.028.

Cumin C et al. (2022) ‘Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways.’, Cell reports, 40(7), p. 111181. Available at: https://doi.org/10.1016/j.celrep.2022.111181.

Diamantopoulou Z et al. (2022) ‘The metastatic spread of breast cancer accelerates during sleep.’, Nature, 607(7917), pp. 156–162. Available at: https://doi.org/10.1038/s41586-022-04875-y.

Fedier A et al. (2022) ‘Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines.’, International journal of oncology, 61(1). Available at: https://doi.org/10.3892/ijo.2022.5379.

Filippi V et al. (2022) ‘Extramedullary haematopoiesis presenting as an adnexal mass in a patient with β-thalassaemia.’, BMJ case reports, 15(6). Available at: https://doi.org/10.1136/bcr-2022-249422.

Zwimpfer TA et al. (2022) ‘Comparison of 2D 4K vs. 3D HD laparoscopic imaging systems using a pelvitrainer model: a randomized controlled study.’, Updates in surgery, 74(3), pp. 1137–1147. Available at: https://doi.org/10.1007/s13304-021-01195-0.

McLaughlin PMJ et al. (2022) ‘Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial.’, BMC cancer, 22(1), p. 508. Available at: https://doi.org/10.1186/s12885-022-09555-8.

Ehrbar V. et al. (2022) ‘Managing Cancer as a Family Disease - Feasibility, Satisfaction and Family Functioning after Short-Time Counselling for Families with Parental Cancer’, Family Journal, 30(2), pp. 200–208. Available at: https://doi.org/10.1177/10664807211052484.

Steffens D et al. (2022) ‘The double S technique to achieve aesthetic flat closure after conventional mastectomy.’, World journal of surgical oncology, 20(1), p. 42. Available at: https://doi.org/10.1186/s12957-022-02515-3.

Vigo F et al. (2022) ‘An interdisciplinary team-training protocol for robotic gynecologic surgery improves operating time and costs: analysis of a 4-year experience in a university hospital setting.’, Journal of robotic surgery, 16(1), pp. 89–96. Available at: https://doi.org/10.1007/s11701-021-01209-4.

Amstad, Gabriela et al. (2022) ‘Perioperative management with ferric carboxymaltose and tranexamic acid to reduce transfusion rate in gynaecological carcinoma surgery (TRANAFER-Study): study protocol for a single-blind, monocentre, randomised trial’, BMJ Open, 12. Available at: https://doi.org/10.1136/bmjopen-2021-057381.

Felder L, Heinzelmann-Schwarz V and Kavvadias T (2022) ‘How does colpocleisis for pelvic organ prolapse in older women affect quality of life, body image, and sexuality? A critical review of the literature.’, Women’s health (London, England), 18, p. 17455057221111067. Available at: https://doi.org/10.1177/17455057221111067.

Natoli, Marina et al. (2022) ‘Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors’, Journal for ImmunoTherapy of Cancer, 10. Available at: https://doi.org/10.1136/jitc-2022-005548.

Sarki, Mahesh. et al. (2022) ‘Intention to inform relatives, rates of cascade testing, and preference for patient-mediated communication in families concerned with hereditary breast and ovarian cancer and lynch syndrome: the Swiss CASCADE Cohort’, Cancers. 23.03.2022, 14(7). Available at: https://doi.org/10.3390/cancers14071636.

Schwab, Fabienne D. et al. (2022) ‘MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies’, Microsystems and Nanoengineering, 8. Available at: https://doi.org/10.1038/s41378-022-00467-y.

Vetter, Marcus et al. (2022) ‘Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment’, International Journal of Molecular Sciences, 23. Available at: https://doi.org/10.3390/ijms232214242.

Fischerova D et al. (2021) ‘Terms, definitions and measurements to describe sonographic features of lymph nodes: consensus opinion from the Vulvar International Tumor Analysis (VITA) group.’, pp. 861–879. Available at: https://doi.org/10.1002/uog.23617.

Koelzer VH et al. (2021) ‘Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform.’, Immuno-oncology technology, 10. Available at: https://doi.org/10.1016/j.iotech.2021.100034.

Heinzelmann-Schwarz, Viola (2021) ‘Recent advances in breast cancer’, Schweizer Zeitschrift fur Gynakologie, null, p. 1.

Heinzelmann-Schwarz, Viola (2021) ‘Editorial’, Schweizer Zeitschrift fur Gynakologie, null, p. 1.

Irmisch, Anja et al. (2021) ‘The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support’, Cancer Cell, 39, pp. 288–293. Available at: https://doi.org/10.1016/j.ccell.2021.01.004.

Jacob F et al. (2021) ‘High-grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer.’, Molecular oncology, 15(1), pp. 91–103. Available at: https://doi.org/10.1002/1878-0261.12811.

Kim, Sue et al. (2021) ‘Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study’, JMIR Research Protocols. 11.06.2021, 10(6). Available at: https://doi.org/10.2196/26264.

Sobottka, Bettina et al. (2021) ‘Establishing standardized immune phenotyping of metastatic melanoma by digital pathology’, Laboratory Investigation, 101, pp. 1561–1570. Available at: https://doi.org/10.1038/s41374-021-00653-y.

Zeiter D et al. (2021) ‘L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapy.’, Journal of Cancer, 12(21), pp. 6401–6410. Available at: https://doi.org/10.7150/jca.59283.

Coelho R et al. (2020) ‘Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation.’, Oncogenesis, 9(6), p. 61. Available at: https://doi.org/10.1038/s41389-020-00246-2.

Trüb M et al. (2020) ‘Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer.’, Journal for immunotherapy of cancer, 8(2). Available at: https://doi.org/10.1136/jitc-2019-000238.

Heinzelmann-Schwarz V et al. (2020) ‘Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?’, Journal of cancer research and clinical oncology, 146(3), pp. 695–704. Available at: https://doi.org/10.1007/s00432-019-03091-y.

Le Page C et al. (2020) ‘Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.’, Gynecologic oncology, 156(2), pp. 377–386. Available at: https://doi.org/10.1016/j.ygyno.2019.11.019.

Wieser S et al. (2020) ‘Reply to comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647.’, 150. Available at: https://doi.org/10.4414/smw.2020.20180.

Terraneo N et al. (2020) ‘L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population.’, Cancers, 12(1). Available at: https://doi.org/10.3390/cancers12010217.

Estermann M et al. (2020) ‘Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion.’, PloS one, 15(12), p. e0241500. Available at: https://doi.org/10.1371/journal.pone.0241500.

Huang, Yen-Lin et al. (2020) ‘Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis’, eLife, 9, p. e59442. Available at: https://doi.org/10.7554/elife.59442.

Montagna G et al. (2020) ‘The impact of depression on adherence to organized and opportunistic breast cancer screening.’, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 29(1), pp. 53–59. Available at: https://doi.org/10.1097/cej.0000000000000520.

Labidi-Galy SI et al. (2019) ‘Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers.’, Gynecologic oncology, 155(2), pp. 262–269. Available at: https://doi.org/10.1016/j.ygyno.2019.09.008.

Montavon C et al. (2019) ‘Outcome in serous ovarian cancer is not associated with LATS expression.’, Journal of cancer research and clinical oncology, 145(11), pp. 2737–2749. Available at: https://doi.org/10.1007/s00432-019-03037-4.

Baettig F et al. (2019) ‘Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response.’, Journal for immunotherapy of cancer, 7(1), p. 281. Available at: https://doi.org/10.1186/s40425-019-0742-6.

Hüttenhain R et al. (2019) ‘A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.’, Molecular & cellular proteomics : MCP, 18(9), pp. 1836–1850. Available at: https://doi.org/10.1074/mcp.ra118.001221.

Szczerba BM et al. (2019) ‘Neutrophils escort circulating tumour cells to enable cell cycle progression’, Nature, 566(7745), pp. 553–557. Available at: https://doi.org/10.1038/s41586-019-0915-y.

Gkountela S et al. (2019) ‘Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding’, Cell, 176(1-2), pp. 98–112.e14. Available at: https://doi.org/10.1016/j.cell.2018.11.046.

Claus, Christina et al. (2019) ‘Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy’, Science Translational Medicine, 11(496), p. eaav5989. Available at: https://doi.org/10.1126/scitranslmed.aav5989.

Jurga-Karwacka A et al. (2019) ‘A forgotten disease: Pelvic congestion syndrome as a cause of chronic lower abdominal pain.’, PloS one, 14(4), p. e0213834. Available at: https://doi.org/10.1371/journal.pone.0213834.

Montagna, Giacomo et al. (2019) ‘Fibroepithelial Breast Lesion: When Sequencing Can Help to Make a Clinical Decision. A Case Report’, Clinical breast cancer, 19(1), pp. e1–e6. Available at: https://doi.org/10.1016/j.clbc.2018.10.007.

Nikolaidis, Christos et al. (2019) ‘Challenges and opportunities for cancer predisposition cascade screening for hereditary breast and ovarian cancer and lynch syndrome in Switzerland : findings from an international workshop’, Public Health Genomics, 21(3-4), pp. 121–132. Available at: https://doi.org/10.1159/000496495.

Saner FA et al. (2019) ‘Fibrin-thrombin sealant does not reduce lymphocele formation in patients with inguinofemoral lymphadenectomy for vulvar cancer.’, Cancer management and research, 11, pp. 3575–3582. Available at: https://doi.org/10.2147/cmar.s197143.

Vetter M et al. (2018) ‘Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer.’, Breast cancer research : BCR. 20.11.2018, 20(1), p. 141. Available at: https://doi.org/10.1186/s13058-018-1067-y.

Stanczak, Michal A et al. (2018) ‘Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells.’, The Journal of clinical investigation. 24.09.2018, 128(11), pp. 4912–4923. Available at: https://doi.org/10.1172/jci120612.

Wieser S et al. (2018) ‘Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data.’, Swiss medical weekly. 29.07.2018, 148, p. w14647. Available at: https://doi.org/10.4414/smw.2018.14647.

Montavon, Celine et al. (2018) ‘Diaphragmatic smears are not of additional benefit in the detection of peritoneal spread in gynecological cancers.’, Experimental and therapeutic medicine. 13.03.2018, 15(5), pp. 4199–4204. Available at: https://doi.org/10.3892/etm.2018.5957.

Dueckelmann AM et al. (2018) ‘Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO Switzerland.’, Archives of gynecology and obstetrics, 297(4), p. 847. Available at: https://doi.org/10.1007/s00404-018-4715-7.

Dueckelmann AM et al. (2018) ‘The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the ‘Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)’, the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology.’, Archives of gynecology and obstetrics, 297(4), pp. 837–846. Available at: https://doi.org/10.1007/s00404-018-4673-0.

Heinzelmann-Schwarz V et al. (2018) ‘Letrozole may be a valuable maintenance treatment in high-grade serous ovarian cancer patients.’, Gynecologic oncology. 20.11.2017, 148(1), pp. 79–85. Available at: https://doi.org/10.1016/j.ygyno.2017.10.036.

Jacob, Francis et al. (2018) ‘Transition of Mesenchymal and Epithelial Cancer Cells Depends on α1-4 Galactosyltransferase-Mediated Glycosphingolipids’, Cancer Research, 78(11), pp. 2952–2965. Available at: https://doi.org/10.1158/0008-5472.can-17-2223.

Montavon Sartorius C et al. (2018) ‘Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers.’, Cancer management and research. 17.10.2018, 10, pp. 4709–4718. Available at: https://doi.org/10.2147/cmar.s174777.

Montavon Sartorius C et al. (2018) ‘ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer.’, PloS one. 29.03.2018, 13(3), p. e0195213. Available at: https://doi.org/10.1371/journal.pone.0195213.

Anugraham, Merrina et al. (2017) ‘Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma’, MOLECULAR ONCOLOGY. WOS.SCI, 11, pp. 1595–1615. Available at: https://doi.org/10.1002/1878-0261.12134.

Magaton IM et al. (2017) ‘Spontaneous Remission of Severe Systemic Langerhans Cell Histiocytosis with Bladder Involvement: A Case Study.’, 10(3). Available at: https://doi.org/10.1159/000480696.

Kohler, Reto S. et al. (2017) ‘MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells.’, Gynecologic oncology, 145(1), pp. 159–166. Available at: https://doi.org/10.1016/j.ygyno.2017.02.016.

Kornig, M. P. et al. (2017) ‘Intra-, peri- and postoperative complications in pelvic organ prolapse surgery in elderly women’. WILEY, 124.

Pochechueva T et al. (2017) ‘Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients.’, Journal of ovarian research. 10.02.2017, 10(1), p. 8. Available at: https://doi.org/10.1186/s13048-017-0305-8.

Katapodi, Maria C. et al. (2017) ‘Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol’, JMIR Research Protocols. 20.09.2017, 6(9). Available at: https://doi.org/10.2196/resprot.8138.

Reina H. and Manedgold-Brauer G. (2017) ‘Triagierung von Patientinnen mit Adnexbefunden’, info@gynäkologie [Preprint].

Jacob, F. et al. (2016) ‘HIGH-GRADE SEROUS OVARIAN AND PERITONEAL CANCERS DISPLAY DISTINCT GENETIC AND POST-TRANSLATIONAL SIGNATURES -A CRITERION TO TREAT THEM DIFFERENTLY?’ LIPPINCOTT WILLIAMS & WILKINS, 26.

Knipprath, A. M. et al. (2016) ‘Molecular characterization and comparison of epithelial ovarian carcinoma (EOC) and primary peritoneal carcinoma (PCC)’. OXFORD UNIV PRESS, 27. Available at: https://doi.org/10.1093/annonc/mdw374.27.

Kohler, R. S. et al. (2016) ‘LOW MGAT3 EXPRESSION IDENTIFIES LONG-TERM SURVIVORS WITH HIGH GRADE SEROUS OVARIAN CANCER’. LIPPINCOTT WILLIAMS & WILKINS, 26.

Katsara, Alkisti et al. (2016) ‘Long-term quality of life, satisfaction, pelvic floor symptoms and regret after colpocleisis’, Archives of gynecology and obstetrics, 294(5), pp. 999–1003. Available at: https://doi.org/10.1007/s00404-016-4158-y.

Kohler, R. S. et al. (2016) ‘Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients’, Oncotarget, 7(32), pp. 51674–51686. Available at: https://doi.org/10.18632/oncotarget.10543.

Manegold-Brauer, G. et al. (2016) ‘Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting’, Int J Gynecol Cancer, 26(6), pp. 1062–9. Available at: https://doi.org/10.1097/igc.0000000000000718.

Pochechueva, T. et al. (2016) ‘Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients’, PLoS One, 11(10), p. e0164230. Available at: https://doi.org/10.1371/journal.pone.0164230.

Schreiner, Jens et al. (2016) ‘Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptor’, Oncoimmunology, 5(2), p. e1062969. Available at: https://doi.org/10.1080/2162402x.2015.1062969.

Decollogne, Stéphanie et al. (2015) ‘Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells’, Gynecologic Oncology, 138(2), pp. 363–71. Available at: https://doi.org/10.1016/j.ygyno.2015.06.018.

Henry, Claire et al. (2015) ‘Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion’, Oncotarget, 6(37), pp. 40310–26. Available at: https://doi.org/10.18632/oncotarget.5643.

Manegold-Brauer, Gwendolin and Heinzelmann-Schwarz, Viola (2015) ‘Comment on the letter: the mass cannot be classified as malignant’, Archives of Gynecology and Obstetrics, 291(3), p. 475. Available at: https://doi.org/10.1007/s00404-014-3558-0.

Jacob F et al. (2014) ‘The glycosphingolipid P₁ is an ovarian cancer-associated carbohydrate antigen involved in migration.’, British journal of cancer. 28.08.2014, 111(8), pp. 1634–45. Available at: https://doi.org/10.1038/bjc.2014.455.

Anugraham, Merrina et al. (2014) ‘Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status’, Molecular and Cellular Proteomics, 13(9), pp. 2213–32. Available at: https://doi.org/10.1074/mcp.m113.037085.

Ford, Caroline et al. (2014) ‘The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer’, Gynecologic oncology, 134(2), pp. 338–345. Available at: https://doi.org/10.1016/j.ygyno.2014.06.004.